EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chemosensitizer Effects of Cisplatin- and 5-Fluorouracil-Treated Hepatocellular Carcinomas by Lidocaine

Teng-Wei Chen, Hsiu-Lung Fan, Shu-Ting Liu, Shih-Ming Huang iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26157137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Teng-Wei Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei City 114, Taiwan. Hauptthemen laut MEDLINE: Lidocaine, Fluorouracil, Carcinoma, Hepatocellular, Cisplatin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tri-Service General Hospital, Taiwan, Teh-Tzer Study Group for Human Medical Research Foundation, Taiwan, Tri-Service General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Approximately 90% of liver cancer cases are classified as hepatocellular carcinomas (HCCs), with chemotherapy and immunotherapy being the most recommended treatment options. While conventional chemotherapy specifically targets rapidly dividing cancer cells, it can also impact on healthy cells that are proliferating quickly. This collateral damage to healthy cells, along with the potential for cancer cells to develop resistance, presents significant challenges for conventional chemotherapy in liver cancer patients. Hepatic artery infusion of chemotherapy (HAIC) generally leads to reduced toxicity and fewer side effects. The process of catheter insertion is usually performed under local anesthesia, with lidocaine being the preferred choice to combine with various chemotherapeutics in HCC treatment. In our study, we explored the effects of repurposing lidocaine in combination with cisplatin or 5-fluorouracil (5-FU) on two HCC cell lines, HepG2 and Hep3B. Our cytotoxicity analysis revealed that lidocaine functions as a chemosensitizer for cisplatin and 5-FU in both HepG2 and Hep3B cells. Specifically, we observed an increase in the subG1 population and a reduction in cytosolic reactive oxygen species in cisplatin- or 5-FU-treated HepG2 and Hep3B cells. Interestingly, lidocaine selectively decreased the reduced/oxidized glutathione ratio in cisplatin- or 5-FU-treated HepG2 cells but not in Hep3B cells. Furthermore, lidocaine induced endoplasmic reticulum stress, apoptosis, mitochondrial membrane depolarization, lipid peroxidation, and autophagy while suppressing cellular proliferation HepG2 and Hep3B cells. In conclusion, our study demonstrates the synergistic potential of combining lidocaine with cisplatin or 5-FU for the treatment of HCC, indicating that lidocaine may serve as an effective chemosensitizer. These findings highlight a new clinical advantage of using repurposing lidocaine as a chemosensitizer in the current HAIC procedure, suggesting that this combination warrants further exploration through rigorous clinical trials. In the future, we can better optimize therapeutic regimens, potentially leading to improved patient outcomes in HCCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LidocaineFluorouracilCarcinoma, HepatocellularCisplatinLiver NeoplasmsAntineoplastic AgentsHumansHep G2 CellsCell Line, TumorReactive Oxygen SpeciesApoptosisCell ProliferationDrug Synergism

Stichwörter der Autor:innen

chemotherapyendoplasmic reticulum stresshepatic artery infusion chemotherapylidocainereactive oxygen species

Substanzen

LidocaineFluorouracilCisplatinReactive Oxygen SpeciesAntineoplastic Agents

Autor:innen und Institutionen

  • Division of General Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei City 114, Taiwan.
  • Department of Biochemistry, National Defense Medical Center, Taipei City 114, Taiwan.

ORCID-Profile: Shih-Ming Huang

Förderung

  • Tri-Service General Hospital, Taiwan
  • Teh-Tzer Study Group for Human Medical Research Foundation, Taiwan
  • Tri-Service General Hospital
  • Teh-Tzer Study Group for Human Medical Research Foundation

Zitieren

APA

Chen, T. W., Fan, H. L., Liu, S. T., & Huang, S. M. (2025). Chemosensitizer Effects of Cisplatin- and 5-Fluorouracil-Treated Hepatocellular Carcinomas by Lidocaine. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157137

Vancouver

Chen TW, Fan HL, Liu ST, Huang SM. Chemosensitizer Effects of Cisplatin- and 5-Fluorouracil-Treated Hepatocellular Carcinomas by Lidocaine. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157137

BibTeX
@article{Chen2025,
  author = {Chen, Teng-Wei and Fan, Hsiu-Lung and Liu, Shu-Ting and Huang, Shih-Ming},
  title = {Chemosensitizer Effects of Cisplatin- and 5-Fluorouracil-Treated Hepatocellular Carcinomas by Lidocaine},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26157137}
}
Kostenlos starten →